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Nontuberculous Mycobacterial Lung Disease Caused by Mycobacter-
ium lentiflavum in a Patient with Bronchiectasis
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We report a rare case of lung disease caused by Mycobacterium lentiflavum in a previously healthy woman. A 
54-year-old woman was referred to our hospital due to chronic cough and sputum. A computed tomography scan 
of the chest revealed bilateral bronchiectasis with bronchiolitis in the right middle lobe and the lingular division 
of the left upper lobe. Nontuberculous mycobacteria were isolated twice from three expectorated sputum 
specimens. All isolates were identified as M. lentiflavum by multilocus sequence analysis based on rpoB, hsp65, 
and 16S rRNA fragments. To the best of our knowledge, this is the first documented case of M. lentiflavum lung 
disease in an immunocompetent adult in Korea. 
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Introduction
  Mycobacterium lentiflavum organisms are slow grow-
ing, tiny yellow nontuberculous mycobacteria (NTM) 
first identified in 19961. As with other NTM, M. lenti-
flavum has been isolated from soil and water samples 
around world2. It is a rare cause of human disease and 
has been reported to have clinical importance primarily 
in young children with cervical lymphadenitis and in 
immunocompromised patients3-5. Recently, however, a 
few cases of chronic pulmonary disease caused by M. 
lentiflavum in immunocompetent patients have been re-
ported2,6-8.
  Although the isolation of M. lentiflavum from clinical 
specimens has been reported in Korea, the infectious 
organisms seemed to be colonizers in the destructed 
lung due to previous tuberculosis9. Here, we report a 
very rare case of M. lentiflavum lung disease associated 
with bronchiectasis in an immunocompetent patient.
Case Report
  A 54-year-old woman was referred to our hospital 
due to chronic cough and sputum, which developed 
three years earlier. She had been a healthy, non-smoker 
up to this point, with the exception of pulmonary tuber-
culosis 10 years prior. Laboratory results, including im-
munoglobulin levels, were normal with the exception 
of an elevated erythrocyte sedimentation rate to 82 
mm/hr. She had no risk factors for human immuno-
deficiency virus infection.
  A chest radiography revealed bilateral multifocal 
tram-track signs. A computed tomography scan of the 
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Figure 1. A 54-year-old woman with bronchiectasis and nontuberculous mycobacterial lung disease caused by 
Mycobacterium lentiflavum. (A) A chest radiography reveals bilateral multifocal tram-track signs (white arrows). (B) A
transverse chest computed tomography (CT) scan (2.5-mm-section thickness) on the level with the right inferior pulmo-
nary vein reveals bilateral bronchiectasis (black arrowheads) in the right middle lobe and the lingular segment of the
left upper lobe. (C) A chest CT scan obtained on the level with the superior segmental bronchus of the left lower lobe
reveals bilateral bronchiolitis in both lungs (white arrowheads).
chest revealed bilateral bronchiectasis and bronchiolitis 
in the right middle lobe and the lingular division of the 
left upper lobe (Figure 1). There was no evidence of 
cystic fibrosis or other common causes of bronchiec-
tasis. NTM were isolated twice from three consecutively 
expectorated sputum specimens.
  Initial identification of the isolated NTM was un-
successful using the polymerase chain reaction (PCR)- 
reverse blot hybridization assay (REBA) method based 
on the rpoB gene (REBA Myco-ID; M&D Inc., Wonju, 
Korea). No specific species could be assigned using this 
method due to a lack of reference sequences. There-
fore, we used multilocus sequence analysis (MLSA) 
based on hsp65, rpoB, and 16S rRNA fragments to de-
termine their taxonomic affiliations. Genomic DNA of 
the isolates was extracted using a commercially avail-
able kit (QIAamp DNA Mini kit; Qiagen, Hilden, 
Germany) and amplified using the appropriate pair of 
primers for each of the three genes. PCR conditions and 
primer sequences are described below. Partial amplifi-
cation of the rpoB gene (723 bp) was performed using 
primers MycoF (5'-GGCAAGGTCACCCCGAAGGG-3') 
and MycoR (5'-AGCGGCTGCTGGGTGATCATC-3')10. 
Partial amplification of the hsp65 gene (439 bp) was 
performed using primers Tb11 (5'-ACCAACGATGGTG-
TGTCCAT-3') and Tb12 (5'-CTTGTCGAACCGCATAC-
CCT-3')11. PCR conditions for these genes were as fol-
lows: 2 minutes at 95oC followed by 35 cycles of 94oC 
for 30 seconds, 60oC for 30 seconds, and 72oC for 2 mi-
nutes, with a final extension step at 72oC for 5 minutes. 
A 564 bp 5'-region of the 16S rRNA gene was amplified 
using primers 16MycF (5'-CGTGCTTAACACATGCAAG-
TCG-3') and 16MycR (5'-GTGAGATTTCACGAACAA-
CGC-3')12. Conditions for 16S rRNA gene amplification 
were as follows: 2 minutes at 95oC followed by 35 cy-
cles of 94oC for 30 seconds, 52oC for 30 seconds, and 
72oC for 1 minute. The amplicons were cloned into the 
pGEM-TEasy vector (Promega, Madison, WI, USA), 
transformed into DH5α Escherichia coli and amplified 
(Invitrogen, Karlsruhe, Germany). Clones were sequen-
ced using the ABI Prism d-Rhodamine dye terminator 
cycle sequencing ready reaction kit (Applied Biosys-
tems, Foster City, CA, USA). Sequencing reactions were 
recorded with an ABI Prism 3100 DNA sequencer fol-
lowing the standard protocol of the supplier (Applied 
Biosystems). The sequences were compared by refer-
ring to publically available sequence in the National 
Center for Biotechnology Information GenBank data-
base13 and the Ribosomal Differentiation of Medical 
Micro-organisms (RIDOM) database14. Homogeneity val-
ues above 99% were considered significant. M. lenti-
flavum was subsequently identified as the most closely 
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related species for which the sequences of the three 
genes were available in GenBank (accession nos. 
EU109300 for rpoB, AF547851 for hsp65, and GU142924 
for 16S rRNA).
  Five months after initial sputum cultures, the patient 
continued to have a mild cough and sputum. Additional 
sputum culture 4 months after the initial sputum exami-
nations was negative. She was reluctant to receive 
long-term antibiotic therapy and refused further fol-
low-up. Therefore, the long-term outcome of this pa-
tient is not available.
Discussion
  NTM are a well-known cause of chronic pulmonary 
disease. Among the most commonly isolated species are 
the M. avium complex, M. abscessus, and M. kansasii, 
but other NTM species have also been described as the 
cause of lung disease. To the best of our knowledge, 
this is the first documented case of M. lentiflavum lung 
disease in an immunocompetent adult in Korea, in 
which the etiologic organism was confirmed using 
MLSA based on rpoB, hsp65, and 16S rRNA fragments. 
  M. lentiflavum is a recently described slowly growing 
NTM1. It has been isolated primarily from lymph nodes 
of young children3, while isolations from other sites, in-
cluding respiratory specimens, have been frequently de-
scribed in immunocompromised patients4. M. lenti-
flavum lung disease in immunocompetent patients has 
rarely been described in the literature2,6-8, and the iso-
lation of NTM always raises doubts about clinical 
significance. Our case confirms the potential pathoge-
nicity of M. lentiflavum in chronic pulmonary disease.
  However, the clinical significance of the isolation of 
M. lentiflavum in our case may be controversial, be-
cause of relatively short follow-up periods and small 
number of sputum acid-fast bacilli (AFB) analysis. As 
the diagnostic criteria for NTM lung disease are not pro-
ven pertinence to less common and low-virulence NTM, 
the patients with repeated isolations of low-virulence 
NTM require careful clinical evaluation and collection 
of multiple specimens for AFB analysis over time15. 
Considering that M. lentiflavum is known to have 
low-virulence, the patients may need to be followed 
with additional sputum examinations for longer time.
  M. lentiflavum is phylogenetically related to other 
slow-growing NTM species such as M. avium, M. gena-
vense, and M. simiae1. Traditional biochemical and/or 
phenotypic features of M. lentiflavum are not dis-
tinguishable from those of these closely related NTM 
species. Therefore, M. lentiflavum may have been pre-
viously misidentified as M. avium complex or M. sim-
iae1,4. Accurate identification of the isolated NTM spe-
cies is very important when initiating a treatment and 
selecting an antimicrobial regimen. However, M. lenti-
flavum cannot be identifiable by commercial kit for the 
identification of NTM species, such as PCR-restriction 
fragment length of polymorphism analysis or REBA 
Myco-ID based on the rpoB gene, because there were 
not included newly defined or infrequently species, es-
pecially for M. lentiflavum. Therefore, the prevalence 
of M. lentiflavum lung disease in Korea may be 
underestimated.
  In conclusion, M. lentiflavum should be considered 
a possible etiologic pathogen of the nodular bron-
chiectatic form of NTM lung disease. We demonstrate 
here that diagnosis of M. lentiflavum can be verified by 
multilocus sequence analysis of rpoB, hsp65, and 16S 
rRNA fragments in clinical isolates.
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